Antibody production relies on diverse technologies. Biointron reviews methods from hybridoma to recombinant platforms that power research and drug development.
Discover how phage display technology enables high-throughput screening of antibodies, peptides, and therapeutic proteins to accelerate drug discovery and protein engineering.
From hybridomas to recombinant platforms, antibody production has evolved. Biointron reveals ten insights into methods that ensure reliable supply and scientific progress.
Explore phage display technology for antibody discovery, drug development, and vaccine research, and its role in engineering high-affinity monoclonal antibodies and peptide drugs.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.
